SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

A room full of agents is not a software factory

Why are AI providers lowering prices even as usage expands?

OpenAI hit pause, attackers haven’t. Here’s what security leaders must do next

Claude Code creator's prompting formula: Say what you want and let AI figure out the rest

Buzz

Most popular

Daily

Weekly

1

Israel loses $1 billion Apache deal after failing to find $288 million in funding

2

Nvidia hits record $5.65 trillion as SpaceX seeks $40 billion to buy its AI chips

3

Israeli startup raises $5 million to rethink one of surgery's most invasive procedures

4

Israel to end private recruitment of construction workers from India and Sri Lanka

5

Foreign investors are pulling back from Israeli stocks as appetite for banks collapses

pharmaceutical

4 stories about pharmaceutical

בריאות דיגיטלית מדעי החיים רפואה טיפול 2

Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million

06.03.19|Hagar Ravet

The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology

מנכ"ל איליי לילי ישראל דודו גל מנכ"לית פארמה ישראל עידית צ'רנוביץ ומנכ"ל abbvie ישראל רפי בלום

Regulation Hinders Innovative Drug Development in Israel, Executives Say

04.09.17|Naomi Zoreff

Despite Israel's advanced medical infrastructure, excessive red tape steers pharmaceutical companies away

עמיר לונדון מנכ"ל קמהדע

Developer Of Anti-Rabies Drug Jumps on FDA Approval

27.08.17|Dror Reich

The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus

U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices

21.08.17|Dror Reich

Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies